I-SENS acquires U.S. diagnostic device company ‘CoaguSense’

Published: 2016-11-24 14:35:53

Updated: 2016-11-24 14:35:53

On the 22^nd, a biosensor company, I-SENS(CEO Geun-Sig Cha), signed an agreement to acquire 62% of the share of a U.S. blood coagulation monitoring company ‘CoaguSense’ and its control for USD 10.4 million.

According to I-SENS, CoaguSense is a company specializing in monitoring blood coagulation and has technology to monitor and analyze factors related to blood coagulation; the technology make ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.